Toxicity, Censoring, and the Limits of Trial Reporting Bishal Gyawali, MD, PhD

https://www.medscape.com/viewarticle/toxicity-censoring-and-limits-trial-reporting-2026a1000ila Hello, everyone. I'm Dr Bishal Gyawali, a medical oncologist and professor of oncology and public health sciences at Queen's University in Kingston, Canada. I'm very happy to be back with you all, through this Medscape studio at the ASCO 2026 Annual Meeting. I'm not going to talk about any specific trial today, but I want to talk more in general about the atmosphere at ASCO 2026 and how we, as the audience, the consumers of the research coming out of this meeting, should think more critically about the trial results before drawing any conclusions from these results.